West Virginia University Logo

August 6, 2014


SAMHSA Prescription Drug Abuse Weekly Update
Issue 83  |  August 6, 2014
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education and Editorial News Other State and Local News Other Resources Video Request for Proposal National Take-Back Event Take-Back Events and Drop Boxes Save the Date Upcoming Conferences and Workshops


C.E. Martin, N. Longinaker, and M. Terplan. 2014. "Recent Trends in Treatment Admissions for Prescription Opioid Abuse During Pregnancy." Journal of Substance Abuse Treatment, doi:10.1016/j.jsat.2014.07.007.

In the national Treatment Episodes Data Set, the overall proportion of pregnant admissions remained stable at 4 percent from 1992 to 2012. The percentage of admitted pregnant women who reported prescription opioid abuse increased from 2 percent in 1992 to 28 percent in 2012, with the rise concentrated in southern states. Over the 20-year period assessed, the demographic characteristics of pregnant women treated for opioid abuse changed, with younger, unmarried White non-Hispanic women; criminal justice referrals; and women with a psychiatric co-morbidity becoming more common. Only about one third received medication-assisted therapy (MAT), despite MAT being the standard of care for pregnant opioid abusers.

Read more:

House Passes Bill Aimed at Reducing Prescription Drug Abuse
Cristina Marcos, The Hill
July 29, 2014

By voice vote, a "bipartisan" U.S. House of Representatives passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2014 (H.R. 4709) to "establish enforcement standards for prescription drug abuse." (Editor's note: News coverage on this bill draws heavily from press releases produced by the bill's sponsors. The press has failed to note the bill was supported by pharmaceutical suppliers and patient rights groups concerned with ensuring that attempts to control diversion do not hamper cancer patients' ability to access opioid pain relievers. The lead Democratic sponsor is from the home district of Johnson & Johnson.) The bill would allow supply chain members (pharmaceutical companies, wholesalers, and pharmacies) to submit a corrective action plan before having their license revoked or suspended by the Drug Enforcement Administration (DEA). (Editor's note: This provision significantly weakens current DEA enforcement powers, meaning the DEA could not readily repeat the aggressive actions it took to clean up Florida pill mills by suspending or revoking Schedule II licenses of wholesalers and pharmacies that dispensed the black market oxycodone that flooded the East Coast.) The bill would also amend the Controlled Substances Act by 1) restricting DEA's time frame to debate and prompt modifications to scheduling recommended by the Food and Drug Administration (e.g., for extended-release hydrocodone) and 2) narrowing the definition of "imminent danger to public health or safety" so DEA could not act until it demonstrated a drug poses present or foreseeable health risks. Finally, it would require the Department of Health and Human Services to provide Congress with a report on the "obstacles to legitimate patient access to controlled substances" associated with enforcement agencies' efforts to "prevent diversion and abuse of controlled substances."

Read more:

Journal Articles and Reports

D.K. Dhodi, K.C. Patil, and S.B. Bhagat. 2014. "A Study to Evaluate the Prevalence and Pattern of Prescription Drug Abuse Among Medical Students and Resident Doctors in a Tertiary Care Hospital in Mumbai: A Questionnaire Based Study." International Journal of Medical Science and Public Health 3(10).

A survey of 200 undergraduate medical students and 200 resident doctors at Grant Government Medical College and Sir J.J. Group of Hospitals in Mumbai, India, revealed 74.6 percent of men and 54.2 percent of women used prescription drugs at least monthly in the past year without a valid prescription. Twenty-three percent reported daily misuse and 6 percent were still abusing opioids. The drugs most commonly misused were nonsteroidal anti-inflammatory medicines (by male medical students), antihistamines (by male residents), and cough syrup (by female medical students and residents). Eighty percent of the misusers started as undergraduate medical students, and 9 percent started earlier. Self-prescription was the most common mode of obtaining drugs (85 percent). (Editor's note: In India, students go directly from secondary school to an undergraduate medical school, where they graduate as physicians.)

Read more:

T.K. Drazdowski, L. Jäggi, A. Borre, and W.L. Kliewer. 2014. "Use of Prescription Drugs and Future Delinquency Among Adolescent Offenders." Journal of Substance Abuse Treatment, doi:10.1016/j.jsat.2014.07.008.

Increased frequency and recency of nonmedical prescription drug use among adolescent offenders was correlated with increased risk of violence exposure, mental health diagnoses, other drug use, and previous delinquency. However, multivariate analyses found nonmedical use was not a significant predictor of drug-related, non-aggressive, or aggressive repeat delinquency 12 months later. Age, sex, exposure to violence, lower socioeconomic status, heavy alcohol use, and a history of delinquency were the key predictors.

Read more:

P. Mateu–Gelabert, H. Guarino, L. Jessell, and A. Teper. 2014. "Injection and Sexual HIV/HCV Risk Behaviors Associated with Nonmedical Use of Prescription Opioids Among Young Adults in New York City." Journal of Substance Abuse Treatment, doi:10.1016/j.jsat.2014.07.002.

This qualitative study explores the drug use and sexual experiences of nonmedical prescription opioid users as they relate to risk of HIV and HCV transmission. A convenience sample of 46 young adult (ages 18–32) nonmedical prescription opioid users in New York City completed semi-structured interviews. Despite their initial perceptions of prescription opioids as less addictive and safer than illegal drugs, prescription opioid misuse often led to long-term opioid dependence and transition to heroin use and drug injection. Injectors in the sample reported sporadic syringe sharing, frequent sharing of non-syringe injection paraphernalia, and selective sharing with fellow injectors who were presumed "clean" (uninfected). Participants reported little knowledge of HCV injection–related risks and safer injection practices. They also reported engaging in unprotected sex with casual partners, exchange sex, and group sex, and that prescription opioid misuse increases the risk of sexual violence.

Read more:

K.J. Mertz, J.K. Janssen, and K.E. Williams. 2014. "Underrepresentation of Heroin Involvement in Unintentional Drug Overdose Deaths in Allegheny County, PA." Journal of Forensic Sciences, doi:10.1111/1556-4029.12541.

Researchers reviewed investigative and laboratory reports to assess the accuracy of morphine and codeine listings on 2008–10 death certificates in Allegheny County, Pennsylvania. Unintentional overdose deaths were reclassified as heroin related if documentation showed 6-monoacetylmorphine in the blood or urine, "stamp bags" or drug paraphernalia at the scene, history of heroin use, or track marks. Deaths were considered morphine related if notes indicated morphine use, a prescription, or morphine at the scene, and codeine related if the codeine blood level exceeded morphine. Of 112 death certificates listing morphine (but not heroin), 74 met heroin criteria and 21 met morphine criteria. Of 20 deaths listing morphine and heroin, only one met morphine criteria. Of 34 deaths listing codeine, 5 were attributed to codeine.

Read more:

A.A. Monte, K.J. Heard, J.A. Hoppe, V. Vasiliou, and F.J. Gonzalez. 2014. "The Accuracy of Self-Reported Drug Ingestion Histories in Emergency Department Patients." The Journal of Clinical Pharmacology, doi:10.1002/jcph.368.

Researchers used urine screens to investigate the accuracy of self-reported drug ingestion histories for 55 patients with pain or nausea at an urban academic emergency department. Only 31 percent of histories matched the drug screens. Matching rates were 58 percent for prescription drugs, 60 percent for over-the-counter drugs, and 82 percent for illicit drugs. Sixteen patients (29 percent) screened positive for drugs they had not mentioned ever using, including nine (16 percent) who were using unreported opioids.

Read more:

T. Richert. 2014. "Wasted, Overdosed, or Beyond Saving—To Act or Not to Act? Heroin Users' Views, Assessments, and Responses to Witnessed Overdoses in Malmö, Sweden." International Journal of Drug Policy, doi:10.1016/j.drugpo.2014.07.006.

Researchers conducted qualitative interviews with a convenience sample of 35 Swedish heroin users who had witnessed another person's overdose. The heroin users generally had a positive attitude toward assisting peers who had overdosed. A number of factors and circumstances, however, contribute to witnesses experiencing resistance to or ambivalence about responding. The witness's own high, difficulty in assessing the situation's seriousness, unwillingness to disturb someone else's high, uncertainty about the motive behind the overdose and whether the victim wants assistance, and fear of police involvement were common barriers to adequate responses in overdose situations.

Read more:

Substance Abuse and Mental Health Services Administration (SAMHSA). 2014. The TEDS Report: Age of Substance Use Initiation Among Treatment Admissions Aged 18 to 30. Rockville, Md.: SAMHSA, Center for Behavioral Health Statistics and Quality.

In 2011, the Treatment Episode Data Set (TEDS) captured 678,432 substance abuse treatment admissions aged 18 to 30 that included age of initiation for at least one substance of abuse. Those who initiated substance use at 25 or older reported the largest proportions of primary abuse of heroin (35 percent) and prescription pain relievers (33 percent).

Read more:

Professional Education and Editorial

K.M.S. Bastianelli and K.K. Orr. 2014. "Nonprescription Naloxone: Pros and Cons." Journal of the American Pharmacists Association 54:328–29, doi:10.1331/JAPhA.2014.14048.

This letter discusses the pros and cons of nonprescription naloxone. With proper education and training, the drug's over-the-counter version would be more readily available and help save lives. Some health professionals believe deaths could result because people might lack education and avoid contacting emergency medical services. Many states do not include naloxone as part of their Good Samaritan laws.

Read more:

J. Worley. 2014. "Identification and Management of Prescription Drug Abuse in Pregnancy." The Journal of Perinatal and Neonatal Nursing 28(3):196–203, doi:10.1097/JPN.0000000000000039.

The author believes healthcare professionals should use a multidisciplinary approach, be supportive, and maintain a good rapport with pregnant women who abuse prescription drugs. Management includes inpatient hospitalization for detoxification and withdrawal symptoms, and in the case of opiate abuse, medication-assisted opiate therapy for the duration of pregnancy to reduce relapse and improve maternal and fetal outcomes. Other recommendations include referrals to support groups and supportive housing.

Read more:


Use of Illicit Drugs Becomes Part of Silicon Valley's Work Culture
Patrick May and Heather Somerville, San Jose Mercury News
July 28, 2014

This article discusses use of illicit drugs and nonprescription pain relievers among Silicon Valley tech workers. Over the past 6 years, the executive director of Morningside Recovery has seen an influx of tech-related clients abusing Adderall. Provigil, normally used to treat narcolepsy, is also popular, as it helps workers stay awake longer. Experts say very few tech companies use drug testing. Most large firms offer counseling for abusers, but employees avoid these services, fearing they could lose their jobs if word got out about their drug habits.

Read more:

States to Focus on Reducing Prescription Drug Abuse
National Governors Association
July 28, 2014

The National Governors Association selected Michigan, Minnesota, North Carolina, and Wisconsin to participate in a policy academy on prescription drug abuse. The selected states will join Nevada and Vermont in developing comprehensive statewide action plans that rely on the use of data and evidence-based programs. In the next year, states will participate in two, 2-day meetings with other policy academy states; convene an in-state workshop facilitated by National Governors Association Center for Best Practices staff; develop a strategic plan for reducing prescription drug abuse; participate in regular conference calls and other networking activities; and receive customized ongoing technical assistance from National Governors Association staff and known experts.

Read more:

Special Report: The Dangers of Painkillers
Consumer Reports
July 2014

This article and video (2:43 minutes) discuss abuse of prescription narcotics and misuse of over-the-counter drugs. Healthcare providers and the general public harbor outdated and dangerous notions about opioids. Three of the biggest misconceptions are 1) opioids work well for chronic pain, 2) opioids are not addictive when used to treat pain, and 3) extended-release versions are safer. The article also discusses ways to safely use opioids and acetaminophen. Consumer Reports recommends the Food and Drug Administration take two steps to save more lives each year: reconsider approving Zohydro ER and make acetaminophen standards consistent.

Read more:

Study Suggests College Athletes Aware of Drug, Alcohol Risks
Kevin Brockway, The Gainesville Sun
July 26, 2014

Surveys from the National Collegiate Athletic Association show college athletes report using prescription pain medication and attention deficit hyperactivity disorder medicine more frequently in 2013 than they did in 2005. The reporter interviews Dr. Keith Carodine, Florida's associate athletic director, about the surveys' findings and what's happening at Division I colleges.

Read more:

S.C. Congressmen Concerned About Painkiller Prescriptions at VA Hospitals
Lauren Sausser, The Post and Courier
July 25, 2014

South Carolina legislators asked the acting Veterans Administration (VA) secretary for data on hydrocodone, oxycodone, methadone, and morphine prescriptions written at three South Carolina facilities between 2011 and 2013. The legislators also asked for details regarding the department's protocols for prescribing these drugs. Lawmakers are worried that VA hospitals in Charleston, Columbia, and Augusta may have become some of the largest "pill mills" in the country.

Read more:

The Success of Prescription Drug Monitoring Programs
Constance Scharff, Psychology Today
July 30, 2014

The Prescription Drug Monitoring Center of Excellence issued a report recommending medical insurers use prescription monitoring program (PMP) data to reduce overdoses, deaths, and healthcare costs associated with abuse of opioids and other prescription drugs. The author sees a continuing need for studies to determine best practices on prescriber education, PMP use, clinical response if addiction or abuse is determined, privacy legislation, and data sharing contracts between state PMPs.

Read more:

4 Ways to Manage Prescription Drug Misuse
Tracey Walker, Modern Medicine
July 29, 2014

This article discusses prescription drug misuse statistics in the United States and offers four ways formulary managers can address the problem: being vigilant, refraining from rush judgment on formulary restrictions, contributing to the information exchange, and advocating for the availability of prescription monitoring programs.

Read more:

FedEx Pleads Not Guilty to Illegal Drug Shipping Charges
Karen Gullo, Bloomberg
July 29, 2014

FedEx Corp. pleaded not guilty in a San Francisco federal court to charges it delivered pain pills, anti-anxiety drugs, and other controlled substances for illegal Internet pharmacies. The company was indicted July 17 by a federal grand jury on 15 counts of conspiracy to distribute controlled substances and misbranded drugs and drug trafficking. If convicted, FedEx may face a fine of at least $820 million. The government plans to present an updated indictment to a federal grand jury probing the company by August 28.

Read more:

Addicted to Opiates: The Staggering Impact of Prescription Painkillers
J. Nelson, Psych Central
July 29, 2014

This article takes an in-depth look at various types of prescription pain relievers, the rise in opioid overdoses, and the people at risk for abusing these drugs.

Read more:

Other State and Local News

With Overdose Deaths Rising, U.S. Attorney General Pushes Naloxone
Jack Thurston, WNECN
July 31, 2014

This article and video (2:31 minutes) discuss naloxone use in Vermont. Vermont state troopers carry naloxone and have witnessed successful revivals. Lieutenant David Weiss of St. Michael's College Fire and Rescue Department said his department tends to use the antidote once a month. Winooski Police Chief Steve McQueen said naloxone may be a better fit for rural communities with slower emergency response times. Chief Mike Schirling of the Burlington Police Department doesn't see an urgent need for his officers to carry the drug, because the Burlington Fire Department already does. Since December 2013, the Vermont Health Department and its partners have distributed about 450 naloxone rescue kits directly to addicts and their loved ones. Health Department numbers show these kits have reportedly been used in 46 overdose situations.

Read more:

Massachusetts Medical Society Testifies on Proposed Regulations for the Prescription Monitoring Program
Massachusetts Medical Society
July 30, 2014

This Massachusetts Medical Society testified before the Department of Public Health on proposed regulations for the state's prescription monitoring program (PMP). Though the organization supported many of the proposed regulations, it cautioned they go too far in certain areas, such as requiring use prior to issuing an initial prescription. The society suggested first making PMP use mandatory only for opiates to judge whether computers will accommodate increased demand for the database, to determine the clinical impact of the program on opiate overdoses and addiction, and to see whether a detrimental effect on patients results. It strongly recommended any violations of the Department of Public Health's program rules be referred to an appropriate licensing agency, such as the Board of Registration in Medicine, for determination of facts and issuance of sanctions. Finally, it stated all prescribers must participate, and the program must accommodate real-time data to achieve the advantages of PMP use.

Read more:

Prescription Tracking at 10: Why It Still Has Much to Prove, but Could Be Maine's Best Weapon Against Drug Abuse
Jackie Farwell, Bangor Daily News
July 28, 2014

This article, part one of a two-part series, discusses Maine's nearly 10-year-old prescription monitoring program (PMP). Prescription drug abuse has worsened in the state over most of its existence. Only about 40 percent of Maine's roughly 7,000 controlled drug prescribers participated in the PMP through May 2012. Since participation became mandatory earlier this year, more than 92 percent of the state's prescribers are now enrolled, and use is up 30 percent. Health providers and pharmacists in the Veterans Administration system and methadone clinics can now view the data.

Read more:

Prescription Tracking at 10: Maine Police, Doctors, Lawmakers Disagree on More Stringent Monitoring, Even as Drug Abuse Picture Improves
Jackie Farwell, Bangor Daily News
July 30, 2014

The second half of a two-part series discusses Maine's prescription drug abuse problem. Brent Gallant was addicted to prescription drugs for 15 years, but has now been sober for almost 3 years. Gallant recalls first using Vicodin when his work colleague offered him the pills. A Vietnam veteran also had pills to share. Later, Gallant descended into heroin addiction when pain relievers got too expensive and harder to score, partly because of better tracking by the prescription monitoring program (PMP). Gordon Smith of the Maine Medical Association said the PMP remains the most important tool prescribers have to prevent prescription drug diversion and abuse. Peter Kreiner, principal investigator at the Brandeis Research Center, reported that an indicator of doctor shopping dropped 24 percent in Maine from 2011 to 2012, followed by an 11 percent decrease the next year.

Read more:

Painkiller 'Epidemic' Raising Drug Death Toll
Alex Maragos, WLFI
July 30, 2014

This article and video (3:30 minutes) discuss an unintentional overdose death study by the coroner's office in Tippecanoe County, Indiana. From 1993 to 2013, drug overdoses rose 370 percent—far outpacing the rise in population. From 2003 to 2013, drugs killed 105 people, which was more than three times the number killed by drunk driving. Methadone accounted for more overdose deaths than any other drug in Tippecanoe County from 2003 to 2013.

Read more:

In State, Data-Sharing Prescription Drug Legislation Stalls
Yanan Wang, Pittsburgh Post-Gazette
July 29, 2014

Pennsylvania House Bill 1694 and Senate Bill 1180, which would create a prescription database accessible to doctors and pharmacists, have stalled. The Senate bill sits in committee in the House, where it will likely face amendments that would return it to a vote in the Senate, while the House bill has been awaiting a Senate committee vote since October. Pittsburgh physicians said a statewide prescription monitoring program would help curb pain reliever abuse and addiction, but the American Civil Liberties Union of Pennsylvania opposes both bills, saying they infringe on individuals' privacy.

Read more:

Healthcare Providers Can Help Reduce Prescription Drug Abuse
Kansas Dental Association
July 28, 2014

The Kansas Department of Health and Environment (KDHE) asks providers to carefully consider the following when prescribing drugs: appropriate use, amount, patient education, and monitoring. Consumers should look for safe and effective alternatives to opiates for treating pain and always properly dispose of unused medications. KDHE suggests consumers use a single provider and pharmacy to help manage treatment and comply with their recommendations. The Department urges consumers to discuss medications with their providers and pharmacists and avoid unprescribed drugs. Finally, KDHE encourages consumers to properly store and secure all medications to prevent unintentional ingestion by young children.

Read more:

Overdoses Down, Drug-Related Deaths Up in Hall
Nick Watson, The Times
July 27, 2014

Through July 2014, only one overdose death was recorded in Hall County, Georgia, compared with six deaths in 2013. Drug-related deaths totaled 16 through July, compared with 23 in 2013. Public Information Officer Dave Palmer linked new awareness campaigns and drug take-back programs to the decrease in overdoses. Naloxone is ineffective against Xanax, Georgia's biggest cause of overdoses. The Georgia Bureau of Investigation reported that in 2012, Xanax was found in the toxicology report 222 times (of 686 overdose deaths that year). Oxycodone was second to Xanax, followed by methadone and hydrocodone.

Read more:

Lane Johnson Takes Blame for Suspension
Zach Berman, The Inquirer
July 27, 2014

This article discusses the four-game suspension of Philadelphia Eagles player Lane Johnson for failing the National Football League's performance-enhancing drug test. Johnson took a drug prescribed by his longtime family physician in April. He appealed the ruling, but later took responsibility for the infraction.

Read more:

Prescription Medication Abuse Warning
Kristie Cross, KMZU
July 31, 2014

Missouri State Highway Patrol Sergeant Brent Berhardt discusses the warning signs of prescription drug abuse and where individuals can go to get help. (Duration: 4:53 minutes)

Read more:

To Prevent Robberies, Walgreens Installs Time-Delay Safes in Oklahoma
Erin Conrad, KWTV
July 30, 2014

Walgreens has installed time-delay safes at all of its stores in Tulsa, Oklahoma. The safes are bolted to the floor inside the pharmacy and drugs such as OxyContin go inside. Walgreens didn't disclose how long the delay lasts, but a representative said other states using the system find it takes long enough to deter thieves.

Read more:

Other Resources

State Approaches to Addressing Drugged Driving
Substance Abuse and Mental Health Services Administration, Center for the Application of Prevention Technologies
Accessed July 31, 2014

This document offers examples of how some states are handling drugged driving. It includes a snapshot of policies, strategies, and guidance being implemented to address specific drugs (e.g., prescription drugs and marijuana); related survey questions, when available; data sources used to inform prevention planning; and additional resources to support state and local efforts.

Read more:

The Criminalization of Prescription Drug Use in the United States
Drug Policy Alliance
July 2014

This document discusses unintended consequences of prescription drugs, such as a supply-side crackdown. It also lists health-based interventions supported by the Drug Policy Alliance (DPA). The DPA believes people should not be punished for using or possessing prescription drugs for nonmedical purposes.

Read more:


A Dose of Reality
Working Partners, Columbus, Ohio
February 7, 2014

"A Dose of Reality" is a video developed by Working Partners that encourages American workers to help combat the prescription drug problem. (Duration: 4:08 minutes)


Request for Proposal

Prescription Drug Abuse: Reducing Prescriptions for Opioids
Health Canada
Deadline: August 29, 2014, no later than 4 p.m. EDT

Chronic Pain Management Research Grant
Milbank Foundation
Postmarked by November 1, 2014

Interventions for Youth Who Misuse/Abuse Prescription Stimulant Medications in High School and/or College-Attending Youth (U01)
National Institutes of Health
Deadline: November 13, 2014, 5 p.m.

National Take-Back Event

National Take-Back Initiative
Drug Enforcement Administration
September 27, 2014
10 a.m. to 2 p.m.

National Prescription Drug Take-Back Day aims to provide a safe, convenient, and responsible means for disposing of prescription drugs, while educating the general public about the potential for abuse.

Read more:

Take-Back Events and Drop Boxes

Police Offer Drop-Off Bin for Unneeded Prescriptions
Mark Walker, Argus Leader (Iowa)
July 25, 2014

Prescription Drug Drop Box
Sandy Bee Lynn, The Post Newspapers (Ohio)
July 28, 2014

Prescription Drug Drop-Off Boxes Start This Week in Cumberland County
Amanda St. Hilaire, ABC 27 (Pennsylvania)
July 29, 2014

Please Properly Dispose of Unused Prescription Drugs
Toombs-Montgomery Chamber of Commerce (Georgia)
July 30, 2014

Prescription Drug Drop-Off Boxes Off to a Good Start
Brittany Schmidt, WKBT (Wisconsin)
July 31, 2014

Save the Date

Sixth Annual American Medicine Chest Challenge: National Day of Awareness and Safe Disposal of Rx and OTC Medicine
American Medicine Chest Challenge
November 8, 2014

Upcoming Conferences and Workshops

Prevention of Youth Substance Abuse in Rural Communities Conference: Bringing Hope to Communities in Despair
Coalition for Healthy Youth
August 6–8, 2014
Lancaster, South Carolina

Preventing Prescription Drug Abuse—Non-Members
New Jersey Pharmacists Association
August 7, 2014
Secaucus, New Jersey

Pills Kill: Prescription to Addiction Symposium
City of Santa Clarita, California
August 27, 2014
6:30 p.m.
Santa Clarita Activities Center
20880 Centre Pointe Parkway
Santa Clarita, California

This symposium will take a proactive approach to addressing important drug issues among young people. Attendees will be provided with tools for preventing and identifying abuse. Prior to the symposium, a resource expo will offer additional information, including expertise from addiction and recovery experts.

Read more:

2014 Arkansas Prescription Drug Abuse Summit
University of Arkansas, Criminal Justice Institute
September 10, 2014
Little Rock, Arkansas

27th Annual NPN Prevention Research Conference
National Prevention Network
September 15–18, 2014
Hartford, Connecticut

2014 Harold Rogers PDMP National Meeting
Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center
September 22–24, 2014
Washington, D.C.

142nd Annual Meeting and Exposition
American Public Health Association
November 15–19, 2014
New Orleans, Louisiana
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.